ANIMATION

Curosurf Intratracheal Suspension

Share this animation:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO

Client


Cornerstone Therapeutics

The XVIVO group exemplifies the attributes of indispensable partners for executing complex projects. They match unquestionable scientific knowledge with outstanding creative capacity and solid project management. They’ve been truly valuable teammates.

Account Supervisor, Ogilvy Healthworld
Share this animation: